IU names board of nonprofit for real estate, research and life sciences work
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.
Pamela Whitten, president of Indiana University, will serve as chair of the IU Inc. board of directors.
The 44-acre campus will span from 12th to 16th streets and from Capitol Avenue to Interstate 65 — approximately eight square blocks.
Centessa Pharmaceuticals is developing treatments to address daytime sleepiness and other neurological conditions.
The Indianapolis-based drugmaker is challenging a $183.7 million judgment in a case brought by a pharmacist who alleged Lilly made false claims about rebates to the federal Medicaid program.
The companies developing new weight-loss medicines have a problem: People who don’t lose weight quickly figure out they were assigned to take a placebo and are bailing out of their clinical trials.
The change is expected to save the state’s Medicaid program approximately $63 million annually, but safety-net care providers say the cuts could put them in jeopardy.
Indiana’s largest life sciences companies and research universities are working to make the state an international leader in chemistry innovation — and they’re ready to launch the first step in a plan called Catalyze Indiana.
Eli Lilly and Co. has launched a platform that offers employers coverage options for obesity care through a partnership with 18 digital health programs.
The organization long known as the Central Indiana Corporate Partnership said the new name better reflects the leadership it represents.
Tim Coleman has held positions within information technology at Lilly in research and development, sales and marketing, manufacturing, and human resources.
Low founded seven companies based on intellectual property developed at Purdue, including Endocyte Inc., which he sold to Novartis Inc. in 2018 for $2.1 billion.
The Catalyst Scholars Fund is supported by a $69.4 million grant from Lilly Endowment Inc. to the CICP Foundation Inc. and matching commitments from participating universities.
Senate Bill 189 took aim at a new policy by Indianapolis-based Elevance Health Inc. that cut hospital reimbursement by 10% if an out-of-network clinician was involved with care.
OrthoIndy and Franciscan Health/Forté Sports Medicine and Orthopedics are the first two providers to join Anthem’s HealthSync Designated Orthopedic Network.
The U.S. Centers for Medicare and Medicaid Services alleges the Indianapolis-based health insurer has failed to properly submit required information to federal regulators since 2018.
Dr. Jacob Triplet, at IU Health Ball Memorial Hospital in Muncie, recently began using the Stryker Mako SmartRobotics device — a robotic arm surgical system that assists him during a reverse shoulder replacement.
LillyPod, which occupies 30,000 square feet in a room the size of a football field, is capable of crunching massive amounts of data at high speeds and is expected to help the Lilly discover and develop drugs at a faster pace.
Elanco Animal Health Inc. stock hit a 52-week high this week after the company posted double-digit revenue growth in the fourth quarter, driven by sales of some of its newest products.
Based on the company’s job-creation plans, the Indiana Economic Development Corp. has approved $1.75 million in incentive-based tax credits for the project.
Indiana University Health is suing a company that was hit by a ransomware attack two years ago — an event the health system says cost it $66 million and impacted its ability to process payments.